Cargando…
Modeling timelines for translational science in cancer; the impact of technological maturation
This work examines translational science in cancer based on theories of innovation that posit a relationship between the maturation of technologies and their capacity to generate successful products. We examined the growth of technologies associated with 138 anticancer drugs using an analytical mode...
Autores principales: | McNamee, Laura M., Ledley, Fred D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367812/ https://www.ncbi.nlm.nih.gov/pubmed/28346525 http://dx.doi.org/10.1371/journal.pone.0174538 |
Ejemplares similares
-
Timelines of translational science: From technology initiation to FDA approval
por: McNamee, Laura M., et al.
Publicado: (2017) -
Translational Science by Public Biotechnology Companies in the IPO“Class of 2000”: The Impact of Technological Maturity
por: McNamee, Laura, et al.
Publicado: (2013) -
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
por: Beierlein, Jennifer M., et al.
Publicado: (2017) -
Contribution of NIH funding to new drug approvals 2010–2016
por: Galkina Cleary, Ekaterina, et al.
Publicado: (2018) -
Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016
por: Cleary, Ekaterina Galkina, et al.
Publicado: (2021)